This one could be a hot watch tomorrow. News just out

["Boyd Hammond" <xkekkxrzyds at priest dot com>]

MAJOR NEWS RELEASE AT CLOSE.....STRONG BUY ISSUED BY HOTSTOCKS.COM
. RADAR ALERT ....RADAR ALERT.....RADAR ALERT.....RADAR ALERT


Pacific Sunset Investments Inc.
SYMBOL: PSiV
CURRENT PRICE: .39
5 DAY Projection:  $1.20



How many times have you heard about this????
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,

PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV

 Pacific Sunset Investments Inc. Specializing in Ways to Eliminate Adverse
Drug Reactions
Wednesday July 27, 8:00 pm ET
Helping Save Lives: Now and for Generations to Come


HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--July 27, 2005--Pacific Sunset
Investments Inc. ("Pacific Sunset") (OTC:PSIV - News), who specializes in
Single Nucleotide Polymorphism ("SNP") analysis data, is revealing their
ability to provide physicians with information specific to a patient's
genetic profile.
SNP analysis provides information on genetic predisposition to various
diseases, such as different forms of cancer, cardiovascular abnormalities
and others. Nearly everyday, people are being treated for illnesses and are
unfamiliar with the fact that their bodies may react poorly due to their
genetic makeup. SNP analysis not only takes a preventative approach in major
illnesses, but SNP data can eliminate adverse drug reactions, which have
been determined as a leading cause of hospitalization and death in the
United States. Pacific Sunset's solution provides doctors and hospitals with
the tools necessary to eliminate adverse drug reactions.

At present, SNP data is helping doctors and hospitals to properly treat
patients through understanding a patient's genetic profile. The way SNP is
involved is called pharmacogenomics, in which SNP data detects the
pharmacodynamic pattern which is pertinent for individual patients. Pacific
Sunset will be providing its specialized SNP solution to help doctors and
hospitals save lives.

 CONCLUSION:
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,  Doesn't this say it all?

 A company to watch!

AGGRESSIVE INVESTORS TAKE NOTE NOW!
PUT Pacific Sunset Investments Inc. PSiV
ON YOUR RADAR SCREENS NOW,
AND WATCH THIS COMPANY STARTING NOW

IF YOU ARE
RECEIVING THIS EMAIL, YOU ARE AMONG THE FIRST PUBLIC INVESTORS TO KNOW ABOUT
PSiV !!!!


Disclaimer:
Information within this email contains "forwardlooking statements" within
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking statements". "Forward looking statements" are based on
expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use
of words such as "projects", "foresee", "expects", "will", "anticipates",
"estimates", "believes", "understands" or that by statements indicating
certain actions "may", "could", or "might" occur. Risk factors include
general economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer
and business consumption habits and other factors overwhich the company has
little or no control. The publisher of this newsletter does not represent
that the information contained in this message states all material facts or
does not omit a material fact necessary to make the statements therein not
misleading. All information provided within this email pertaining to
investing, ST0CKs, securities must be understood as information provided and
not investment advice. The publisher of this newsletter advises all readers
and subscribers to seek advice from a registered professional securities
representative before deciding to trade in ST0CKs featured within this
email. None of the material within this report shall be construed as any
kind of investment advice or solicitation. Many of these companies are on
the verge of bankruptcy. You can lose all your money by investing in this
ST0CK. We urge you to read the company's SEC filings now, before you invest.
The publisher of this newsletter is not a registered invstment advisor.
Subscribers should not view information herein as legal, tax, accounting or
investment advice. In compliance with the SecuritiesAct of 1933, Section
17(b), The publisher of this newsletter is contracted to receive two hundred
thousand free trading shares from a third party, not an officer, director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to the
fact that this is a paid advertisement and is not without bias. The party
that paid us has a position in the ST0CK they will sell at anytime without
notice. This could have a negative impact on the price of the ST0CK, causing
you to lose money. All factual information in this report was gathered from
public sources, including but not limited to SEC filings, Company Websites
and Company Press Releases. The publisher of this newsletter believes this
information to be reliable but can make no guarantee as to its accuracy or
completeness. Use of the material within this email constitutes your
acceptance of these terms.